Showing 261 - 280 results of 804 for search '"MSc"', query time: 0.07s Refine Results
  1. 261
  2. 262

    Delayed Supplementation Strategy of Extracellular Vesicles from Adipose-Derived Mesenchymal Stromal Cells with Improved Proregenerative Efficiency in a Fat Transplantation Model by Shan Mou, Yuan Li, Di Sun, Muran Zhou, Jialun Li, Lifeng Chen, Shaokai Liu, Jie Yang, Peng Xiao, Jing Tong, Zhenxing Wang, Jiaming Sun

    Published 2022-01-01
    “…However, MSC-EVs are superior to MSCs in terms of storage and rejection reflection, while immediate administration of MSC-EVs is related to several target cells for most donor cells die within few weeks. …”
    Get full text
    Article
  3. 263

    Optimising Human Mesenchymal Stem Cell Numbers for Clinical Application: A Literature Review by E. Fossett, W. S. Khan

    Published 2012-01-01
    “…This review investigates how factors, age and gender of donor, as well as seeding density can affect MSC expansion. Age and gender of donor have received mixed results from studies, whereas seeding density studies have produced consistent results for numerous MSC sources, favouring lower seeding densities. …”
    Get full text
    Article
  4. 264
  5. 265

    Current Development of Mesenchymal Stem Cell-Derived Extracellular Vesicles by Bingyi Zheng, Xueting Wang, Meizhai Guo, Chi-Meng Tzeng

    Published 2025-01-01
    “…In this review, we summarize the current progress of MSC-EVs and discuss the challenges and future of MSC-EVs.…”
    Get full text
    Article
  6. 266

    Application of biomaterials in mesenchymal stem cell based endometrial reconstruction: current status and challenges by Ling He, Qianrong Li

    Published 2025-01-01
    “…However, challenges such as cell survival and transplantation limit the effectiveness of MSC therapy. Researchers have explored various approaches to enhance the therapeutic efficiency of MSCs. …”
    Get full text
    Article
  7. 267
  8. 268

    Treatment of Hyperoxia-Induced Lung Injury with Lung Mesenchymal Stem Cells in Mice by Yabo Mei, Chong Chen, Hui Dong, Wanqiao Zhang, Yan Wang, Ming Chi, Zhichun Feng

    Published 2018-01-01
    “…Mice in the hyperoxia + L-MSC group were treated with L-MSCs at 3, 7, and 14 days after birth. …”
    Get full text
    Article
  9. 269

    Fate and long-lasting therapeutic effects of mesenchymal stromal/stem-like cells: mechanistic insights by Akram Hoseinzadeh, Seyed-Alireza Esmaeili, Reza Sahebi, Anahita Madani Melak, Mahmoud Mahmoudi, Maliheh Hasannia, Rasoul Baharlou

    Published 2025-02-01
    “…It is hypothesized that the diversity of recipient cells within the inflammatory stroma adjacent to MSCs may potentially serve as a biomarker for predicting the clinical outcome of MSC treatment, while also contributing to the variable outcomes observed with MSC-based therapies. …”
    Get full text
    Article
  10. 270
  11. 271

    Amelioration of premature aging in Werner syndrome stem cells by targeting SHIP/AKT pathway by Hei-Yin Tam, Jiaxing Liu, Tsz-Ching Yiu, Adrian On-Wah Leung, Chang Li, Shen Gu, Owen Rennert, Boxian Huang, Hoi-Hung Cheung

    Published 2025-01-01
    “…The stemness of WRN-deficient MSC was also improved upon pharmacological treatments with the inhibitors. …”
    Get full text
    Article
  12. 272

    Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis by Selma Maacha, Heba Sidahmed, Shana Jacob, Giusy Gentilcore, Rita Calzone, Jean-Charles Grivel, Chiara Cugno

    Published 2020-01-01
    “…MSC-derived secretome mediates beneficial angiogenic effects in a variety of tissue injury-related diseases. …”
    Get full text
    Article
  13. 273

    Apelin-13 Pretreatment Promotes the Cardioprotective Effect of Mesenchymal Stem Cells against Myocardial Infarction by Improving Their Survival by Guona Chen, Xiaoting Liang, Qian Han, Cong Mai, Linli Shi, Zhuang Shao, Yimei Hong, Fang Lin, Mimi Li, Bei Hu, Xin Li, Yuelin Zhang

    Published 2022-01-01
    “…Although mesenchymal stem cell- (MSC-) based therapy has shown promising results for myocardial infarction (MI), low cell survival heavily limits its beneficial effects. …”
    Get full text
    Article
  14. 274

    miRNA in blood-brain barrier repair: role of extracellular vesicles in stroke recovery by Vojtech Sprincl, Vojtech Sprincl, Nataliya Romanyuk

    Published 2025-02-01
    “…This review explores the potential of MSC-derived EVs in mediating neuroprotective and reparative effects on the BBB after ischemic stroke. …”
    Get full text
    Article
  15. 275

    Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis? by Agnese Gugliandolo, Placido Bramanti, Emanuela Mazzon

    Published 2019-01-01
    “…For this reason, more studies and trials are needed to clarify the real effectiveness of MSC-based therapy in ALS.…”
    Get full text
    Article
  16. 276

    Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases by Shan-jing Xu, Li-ping Ye, Wei Wang, Ya-hong Chen, Jian Dong, Xin-li Mao, Shao-wei Li

    Published 2021-01-01
    “…Mesenchymal stem cell (MSC) therapy is a novel treatment for patients with different liver diseases due to its vast expansion potential and distinctive immunomodulatory properties. …”
    Get full text
    Article
  17. 277

    Insight in Hypoxia-Mimetic Agents as Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine by Agata Nowak-Stępniowska, Paulina Natalia Osuchowska, Henryk Fiedorowicz, Elżbieta Anna Trafny

    Published 2022-01-01
    “…Hypoxia-mimetic agents are new potential tools in MSC priming instead of hypoxia incubators or chambers. …”
    Get full text
    Article
  18. 278
  19. 279

    The Influence of Cell Source and Donor Age on the Tenogenic Potential and Chemokine Secretion of Human Mesenchymal Stromal Cells by Weronika Zarychta-Wiśniewska, Anna Burdzińska, Katarzyna Zielniok, Marta Koblowska, Kamila Gala, Piotr Pędzisz, Roksana Iwanicka- Nowicka, Anna Fogtman, Aleksandra Aksamit, Agnieszka Kulesza, Aleksandra Zołocińska, Leszek Pączek

    Published 2019-01-01
    “…Cells were isolated from 24 human donors, 8 for each group: hASC, hBM-MSC Y (age≤45), and hBM-MSC A (age>45). The microarray analysis was performed on RNA isolated from hASC and hBM-MSC A cells. …”
    Get full text
    Article
  20. 280

    Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting β Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice by Jing Xue, Yu Cheng, Haojie Hao, Jieqing Gao, Yaqi Yin, Songyan Yu, Junyan Zou, Jiejie Liu, Qi Zhang, Yiming Mu

    Published 2020-01-01
    “…Mice were divided into five groups: the normal group, the T2D group, the DAC group, the MSC group, and the MSC plus DAC group (MD group). …”
    Get full text
    Article